The characteristics of inhibition of histamine release from human lung fragments by sodium cromoglycate, salbutamol and chlorpromazine.
about
Importance of beta 2-adrenoceptor stimulation in the suppression of intradermal antigen challenge by adrenalineInhibition of histamine release from dispersed human lung and tonsillar mast cells by nicardipine and nifedipineInhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol.The pharmacology and mechanisms of action of histamine H1-antagonists.Biological properties of human skin mast cells.Pharmacology of airway inflammation in asthma.Staub and Bovet Award 1989 lecture. Some aspects of mast cell subtypes from human lung tissue.An explanation of the asthma paradox.Beta agonists and the asthma paradox.Effects of sodium cromoglycate and nedocromil sodium on histamine secretion from human lung mast cells.Use of calcium channel blocking agents in the management of childhood asthma.Formalin sensitivity and differential staining of mast cells in human dermis.Inhibitory effect of inhaled procaterol on anaphylactic bronchoconstriction and thromboxane A2 production in guinea-pigs.Nedocromil sodium inhibits antigen-induced contraction of human lung parenchymal and bronchial strips, and the release of sulphidopeptide-leukotriene and histamine from human lung fragments.Cromoglycate and nedocromil: influence on airway reactivity.Effect of salbutamol, fenoterol, and sodium cromoglycate on the release of heparin from sensitized human lung fragments challenged with Dermatophagoides pteronyssinus allergen.The effects of cremophor EL in the anaesthetized dog.The effects of anti-asthma drugs on mediator release from cultured human mast cellsStatus and prospects of development of antiallergic drugs
P2860
Q24540449-8C807657-BF52-458B-AED3-F91F374BD1F2Q28336159-43451782-9B3B-4CB8-922B-2B8158A3E39BQ35887104-E4157D81-28D1-46B7-AE60-F0BE691DEC8EQ36601549-2B367045-9A5E-43E5-BAB6-1F82093724B5Q37365366-8F68899C-378A-4933-BF8F-2B5D6B16DD71Q37595440-0884FBA3-709E-4D7F-AE55-91274BC2DED3Q37941863-4A3F0AF4-107D-46B2-A004-32FE4357169AQ40710023-B4392A02-43E7-4942-B06F-C3054F89B24BQ40711045-34E7F101-E460-455D-A274-BB3A8144C5F5Q41131943-73B76C0D-6B3E-43A2-8EED-9D4DB7646BA4Q41573684-2E254568-92C9-4E83-B83B-488FF325E91BQ42091758-BFE8FFAD-2574-4AB8-B9AA-6F056E889E67Q42164789-F24A4B88-DE43-40CB-B234-F04D6519A2F0Q42564450-152346CE-602E-44DD-8EF6-3B7C227D3C33Q42906143-0BE9FC50-B16A-4B36-9B61-5A7D589E2474Q53748838-0909031F-22FC-412E-A264-B98C8DD78E5FQ54410133-94385AF9-BB3F-4D62-B4EB-5A89938E6865Q57273216-460B6BAE-9D82-4DEF-BE88-BCA3CB9F5A14Q57775292-00DC854F-BE4F-4127-B75B-941CA8192241
P2860
The characteristics of inhibition of histamine release from human lung fragments by sodium cromoglycate, salbutamol and chlorpromazine.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
1983年论文
@zh
1983年论文
@zh-cn
name
The characteristics of inhibit ...... salbutamol and chlorpromazine.
@en
type
label
The characteristics of inhibit ...... salbutamol and chlorpromazine.
@en
prefLabel
The characteristics of inhibit ...... salbutamol and chlorpromazine.
@en
P2860
P1476
The characteristics of inhibit ...... salbutamol and chlorpromazine.
@en
P2093
P2860
P304
P356
10.1111/J.1476-5381.1983.TB09419.X
P407
P577
1983-04-01T00:00:00Z